Apamin increases 5-HT cell firing in raphe dorsalis and extracellular 5-HT levels in amygdala: A concomitant in vivo study in anesthetized rats

Brain Research

Volumn 1281, Issue , 2009, Pages 35-46

  Crespi, F ^a  

^a GSK   (Italy)

Author keywords

Amygdala; Anesthetized rats; Apamin; Electrophysiology; In vivo voltammetry; Potassium channel; Raphe dorsalis; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; APAMIN; CALCIUM ACTIVATED SLOW POTASSIUM 3; CALCIUM ACTIVATED SLOW POTASSIUM CHANNEL 3; CARBON FIBER; POTASSIUM CHANNEL; SEROTONIN; TETRODOTOXIN; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSENSOR; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; ELECTROPHYSIOLOGY; MALE; MICROELECTRODE; MOLECULAR PROBE; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ACTION POTENTIALS; AMYGDALA; ANESTHESIA; ANIMALS; APAMIN; EXTRACELLULAR SPACE; INJECTIONS, SUBCUTANEOUS; MALE; MICROELECTRODES; MICROINJECTIONS; NEURONS; POTASSIUM CHANNEL BLOCKERS; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGONISTS; SODIUM CHANNEL BLOCKERS; TETRODOTOXIN;

MAMMALIA; RATTUS;

EID: 67649387948     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.05.021     Document Type: Article

References (80)

1. Aghajanian G. LSD and 2-bromo LSD: comparison of the effects of serotonergic neurones in two serotonergic projection areas, the ventral lateral geniculate and amygdala. Neuropharmacology 15 (1976) 521-528
2. Arce E., Simmons A.N., Lovero K.L., Stein M.B., and Paulus M.P. Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology 196 (2008) 661-672
3. Attenburrow M.J., Williams C., Odontiadis J., Reed A., Powell J., Cowen P.J., and Harmer C.J. Acute administration of nutritionally sourced tryptophan increases fear recognition. Psychopharmacology 169 (2003) 104-107
4. Barfod E.T., Moore A.L., and Lidofsky S.D. Cloning and functional expression of a liver isoform of the small conductance Ca(2+)-activated K(+) channel SK3. Am. J. Physiol. Cell. Physiol. 280 (2001) 836-842
5. Bianchi M., Moser C., Lazzarini C., Vecchiato E., and Crespi F. Forced swimming test and fluoxetine treatment:in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes. Exp. Brain Res. 143 (2002) 191-197
6. Bond C.T., Maylie J., and Adelman J.P. Small-conductance calcium-activated potassium channels. Ann. N. Y. Acad. Sci. 868 (1999) 370-378
7. Briley, M., Fillon, G., New Concept in Depression, volume 2, 1998
8. Briley M., and Moret C. 5-HT and antidepressants: in vitro and in vivo release studies. TiPS 14 (1993) 396-397
9. Brodie M.S., McElvain M.A., Bunney E.B., and Appel S.B. Pharmacological reduction of small conductance calcium-activated potassium current (SK) potentiates the excitatory effect of ethanol on ventral tegmental area dopamine neurons. J. Pharmacol. Exp. Ther. 290 1 (1999) 325-333
10. Carboni E., and Di Chiara G. Serotonin release estimated by transcortical dialysis in freely moving rats. Neuroscience 32 (1989) 637-645
11. Charney D.S. Neuroanatomical circuits modulating fear and anxiety behaviors. Acta Psychiatr. Scand. Suppl. (2003) 38-50
12. Congestri F., Formenti F., Sonntag V., Hdou G., and Crespi F. The selective D3 receptor antagonist SB-277011-A potentiates the effect of cocaine on extracellular dopamine in the nucleus accumbens: a dual core-shell voltammetry study in anesthetized rats. Sensors 8 (2008) 6936-6951
13. Cools R., Calder A.J., Lawrence A.D., Clark L., Bullmore E., and Robbins T.W. Individual differences in threat sensitivity predict serotonergic modulation of amygdala response to fearful faces. Psychopharmacology 180 (2005) 670-679
14. Crespi F. In vivo voltammetry with microbiosensor for analysis of neurotransmitter release and metabolism. J. Neurosci. Methods 34 (1990) 53-65
15. Crespi F. In vivo voltammetry and concomitant electrophysiology at a single micro-biosensor to analyse ischaemia, depression and drug dependence. J. Neurosci. Methods 119 (2002) 173-184
16. Crespi F., Sharp T., Maidment N., and Marsden C. Differential pulse voltammetry: simultaneous in vivo measurement of ascorbic acid, catechols and 5-hydroxyindoles in the rat striatum using a single carbon fibre electrode. Brain Res. 322 (1984) 135-138
17. Crespi F., Martin K.F., and Marsden C.A. Nafion coated carbon fibre electrodes combined with differential pulse voltammetry measure 5-HT release in vivo. Neuroscience 27 (1988) 885-896
18. Crespi F., Garratt J., Sleight A., and Marsden C.A. In vivo evidence that 5-HT neuronal firing and release are not correlated with 5-HT metabolism. Neuroscience 35 (1990) 139-144
19. Crespi F., Moebius C., and Neudeck A. Short range differential pulse voltammetry for fast, selective analysis of basal levels of cerebral compounds in vivo. J. Neurosci. Methods 50 (1993) 225-235
20. Crespi F., England T., Ratti E., and Trist D.G. Carbon fibre micro-electrodes for concomitant in vivo electrophysiological and voltammetric measurements: no reciprocal influences. Neurosci. Lett. 188 (1995) 33-36
21. Cruz M., and Pedro A. Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze. Psychopharmacology 182 (2005) 20-28
22. Dawson L.A., and Routledge C. Differential effects of potassium channel blockers on extracellular concentrations of dopamine and 5-HT in the striatum of conscious rats. Br. J. Pharmacol. 116 (1995) 3260-3264
23. Eriksson E., Engberg G., Bing O., and Nissbrandt H. Effects of mCPP on the extracellular concentrations of serotonin and dopamine in rat brain. Neuropsychopharmacology 20 (1999) 287-296
24. Fallon J.H., and Loughlin S.E. Monoamine innervation of the forebrain: colateralization. Brain Res. Bull. 9 (1982) 295-307
25. Freo U., Merico A., Ermani M., and Ori C. Cerebral metabolic effects of fluoxetine, fluvoxamine, paroxetine and sertraline in the conscious rat. Neurosci. Lett. 436 (2008) 148-152
26. Fuxe K. Evidence or the existence of monoamine neurons in the central nervous system IV. The distribution of monoamine terminals in the central nervous system. Acta Physiol. Scand. 64 Suppl. 247 (1965) 37-84
27. Fuxe K., and Ungerstedt U. Localization of 5-hydroxytryptamine uptake in rat brain after intraventricular injection. J. Pharm. Pharmacol. 19 (1967) 335-337
28. Galeotti N., Ghelardini C., Caldari B., and Bartolini A. Effect of potassium channel modulators in mouse forced swimming test. Br. J. Pharmacol. 126 (1999) 1653-1659
29. Garratt J.C., Crespi F., Mason R., and Marsden C.A. Effect of idazoxan on RDN 5-HT neuronal function. Eur. J. Pharmacol. 193 (1991) 87-93
30. Gartside S.E., Hajo's-Korcsok E., Bagdy E., Harsing Jr. L.G., Sharp T., and Hajo' s M. Neurochemical and electrophysiological studies on the functional significance of burst firing in serotonergic neurons. Neuroscience 98 (2000) 295-300
31. Graeff F.G. On serotonin and experimental anxiety. Psychopharmacology 163 (2000) 467-476
32. Gray T.S., and Bingaman E.W. The amygdala: corticotropin-releasing factor, steroids, and stress. Crit. Rev. Neurobiol. 10 (1996) 155-168
33. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., Egan M.F., and Weinberger D.R. Serotonin transporter genetic variation and the response of the human amygdala. Science 297 (2002) 400-403
34. Harmer C.J. 5HT3 antagonism abolishes the emotion potentiated startle effect in humans. Psychopharmacology 186 (2006) 18-24
35. Harmer C.J., Rogers R.D., Tunbridge E., Cowen P.J., and Goodwin G.M. Tryptophan depletion decreases the recognition of fear in female volunteers. Psychopharmacology 167 (2003) 411-417
36. Hervas I., and Artigas F. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors. Eur. J. Pharmacol. 359 (1998) 9-18
37. Hervas I., Bel N., Fernandez G.A., Palacios J.M., and Artigas F. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei. Naunyn-Schmiedeberg. Arch. Pharmacol. 358 (1998) 315-322
38. Hervas I., Queiroz C.M.T., Adell A., and Artigas F. Role of reuptake inhibition and auto-receptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat. Br. J. Pharmacol. 130 (2000) 160-166
39. Hughes M., Romey G., Duval D., Vincent J., and Lazdunski M. Apamin as selective blocker of the calcium dependent potassium chanel in neuroblastoma cells. Voltage clamp and biochemical characterization of the toxin receptor. Proc. Natl. Acad. Sci. U. S. A. 79 (1982) 1308-1312
40. Irwin S. Comprehensive observational assessment: a systematic quantitative procedure for assessing the behavioural and physiologic state of the mouse. Psychopharmacologia 13 (1968) 222-257
41. Kohler M., Hirschberg B., Bond C.T., Kinzie J.M., Marrion N.V., Maylie J., and Adelman J.P. . Small-conductance, calcium-activated potassium channels from mammalian brain. Science 273 (1996) 1677
42. LeDoux J.E. Brain mechanisms of emotion and emotional learning. Curr. Opin. Neurobiol. 2 (1992) 191-197
43. LeDoux J.E. Emotion circuits in the brain. Annu. Rev. Neurosci. 23 (2000) 155-184
44. LeDoux J.E. The emotional brain, fear, and the amygdala. Cell. Mol. Neurobiol. 23 (2003) Nos. 4/5
45. Liu R.J., Van den Pol R.N., and Aghajanian G.K. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J. Neurosci. 22 (2002) 9453-9464
46. Luscher H.R., and Shiner J.S. Computation of action potential propagation and presynaptic bouton activation in terminal arborizations of different geometries. Biophys. J. 58 (1990) 1377-1388
47. Ma Q.P., Yin G.F., Ai M.K., and Han J.S. Serotonergic projections from the nucleus raphe dorsalis to the amygdala in the rat. Neurosci. Lett. 134 (1991) 21-24
48. Maidment N.T., and Marsden C.A. In vivo voltammetric and behavioural evidence for somatodendritic autoreceptor control of mesolimbic dopamine neurones. Brain Res. 338 (1985) 317-325
49. Martin K., Marsden C., and Crespi F. In vivo electrochemistry with carbon fibre electrodes: principles and application to neuropharmacology. Trends Anal. Chem. 7 (1988) 334-339
50. Matos F.F., Rollema H., and Basbaum A.I. Characterization of monoamine release in the lateral hypothalamus of awake, freely moving rats using in vivo microdialysis. Brain Res. 528 (1990) 39-47
51. Mattsson J.L., Spencer P.J., and Albee R.R. A performance standard for clinical and functional observational battery examinations of rats. J. Am. Coll. Toxicol. 15 (1996) 239-254
52. McCown T.J., and Breese G.R. Effects of apamin and nicotinic acetylcholine receptor antagonists on inferior collicular seizures. Eur. J. Pharmacol. 187 (1990) 49-58
53. Messier C., Mourre C., Bontempi B., Sif G., Lazdunski M., and Destrade C. Effect of apamin, a toxin that inhibits Ca(2+)-dependent K+ channels, on learning and memory processes. Brain Res. 551 (1991) 322-326
54. Middlemiss D. Putative 5-HT1 receptor agonist RU24969 inhibits the efflux of 5-HT from rat frontal cortex slices by stimulation of the 5-HT autoreceptor. J. Pharm. Pharmacol. 37 (1984) 434-437
55. Millan M.J. The neurobiology and control of anxious states. Prog. Neurobiol. 70 (2003) 83-244
56. Mo B., Feng N., Renner K., and Forster G. Restraint stress increases serotonin release in the central nucleus of the amygdala via activation of corticotropin-releasing factor receptors. Brain Res. Bull. 76 (2008) 493-498
57. Moscardo E., Maurin A., Dorigatti R., Champeroux P., and Richard S. An optimised methodology for the neurobehavioural assessment in rodents. J. Pharmacol. Tox. Meth. 56 (2007) 239-255
58. Mourre C., Fournier C., and Soumireu-Mourat B. Apamin, a blocker of the calcium-activated potassium channel, induces neurodegeneration of Purkinje cells exclusively. Brain Res. 778 (1997) 405-408
59. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, London
60. Pich E.M., Messori B., Zoli M., Ferraguti F., Solfrini V., Marrama P., Fuxe K., and Agnati L.F. Feeding and drinking responses to neuropeptide Y injections in the paraventricular hypothalamic nucleus of aged rats. Brain Res. 575 (1992) 265-271
61. Pitkanen A., Savander V., and LeDoux J.E. Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala. TINS 20 (1997) 517-523
62. Rauch S.L., Shin L.M., and Wright C.I. Neuroimaging studies of amygdala function in anxiety disorders. Ann. N. Y. Acad. Sci. 985 (2003) 389-410
63. Redfern W.S., Strang I., Storey S., Heys C., and Barnard C. Spectrum of effects detected in the rat functional observational battery following oral administration of non-CNS targeted compounds. J. Pharmacol. Toxicol. Methods 52 (2005) 77-82
64. 1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology 15 (1996) 349-360
65. Romero L., Casanova J.M., Hervas I., Cortes R., and Artigas F. Strategies to optimize the antidepressant action of selective serotonin reuptake inhibitors. In: Skolnick P. (Ed). Antidepressants: Current Trends and Future Directions (1997), Humana Press, Totowa 1-33
66. Roozendaal B., Koolhaas J.M., and Bohus B. The role of the central amygdala in stress and adaption. Acta Physiol. Scand. 161 (1997) 51-54
67. Rouchet N., Waroux O., Lamy C., Massotte L., Scuve'e-Moreau J., Lie'geois J.F., and Seutin V. Channel blockade promotes burst firing in dorsal raphe serotonergic neurons. Eur. J. Neurosci. 28 (2008) 1108-1115
68. Self T., and Crespi F. Electron microscopic and voltammetric analysis of carbon fibre electrode pretreatments. J. Mater. Med. 3 (1992) 418-425
69. Sharp T., Bramwell S.R., and Grahame-Smith D.G. 5-HT1 agonists produce 5-HT release in rat hippocampus in vivo as determined by brain microdialysis. Br. J. Pharmacol. 96 (1989) 283-290
70. Stamford J., Crespi F., and Marsden C.A. In vivo voltammetric methods for monitoring monoamine release and metabolism. Practical Approach Series Monitoring Neuronal Activity (1992), Irl Press at Oxford University Press, Oxford U.K. 113-145
71. Stocker M. Ca(2+)-activated K+ channels: molecular determinants and function of the SK family. Nat. Rev. Neurosci. 5 (2004) 758-770
72. Stocker M., and Pederzani P. Differential distribution of three Ca2+ activated K+ channel subunits SK1, SK2, and SK3 in the adult rat CNS. Mol. Cell. Neurosci. 15 (2000) 476-493
73. Stocker M., Krause M., and Pedarzani P. An apamin-sensitive Ca2+-activated K+ current in hippocampal pyramidal neurons. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 4662-4667
74. Tacconi S., Carletti R., Bunnemann B., Plumpton C., Pich E., and Terstappen G.C. Distribution of the messenger RNA for the small conductance calcium-activated potassium channel SK3 in the adult rat brain and correlation with immunoreactivity. Neuroscience 102 (2001) 205-215
75. Takashi U. Role of 5-HT1A receptors in the modulation of stress-induced lactate metabolism in the medial prefrontal cortex and basolateral amygdala. Psychopharmacology 186 (2006) 218-225
76. Van der Staay F.J., Fanelli R.J., Blokland A., and Schmidt B.H. Behavioral effects of apamin, a selective inhibitor of the SK(Ca)-channel, in mice and rats. Neurosci. Biobehav. Rev. 23 (1999) 1087-1110
77. 1A subtype. Eur. J. Pharmacol. 113 (1985) 463-464
78. Vertes R.P. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J. Comp. Neurol. 313 (1991) 643-668
79. Walter J.T., Alvina K., Womack M.D., Chevez C., and Khodakhah K. Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat. Neurosci. 9 (2006) 389-397
80. Wang R.Y., and Aghajanian G.K. Inhibition of neurons in the amygdala by dorsal raphe stimulation: mediation through a direct serotonergic pathway. Brain Res. 120 (1977) 85-102